FDA shared a post on LinkedIn:
“Starting February 1, 2026, FDA will accept applications for a new pilot program called PreCheck. This program aims to:
- Strengthen America’s pharmaceutical supply chain
- Increase predictability in FDA decision-making
- Facilitate the construction of manufacturing sites in the United States
- Streamline manufacturing facility assessment in advance of specific product applications
More Updates from FDA on OncoDaily.